Dow Jones 30 Stocks SEC Filings — March 03, 2026

03-03-2026

Select Medical Holdings Corporation (NYSE: SEM) entered a definitive merger agreement to be acquired by a consortium led by Robert A. Ortenzio, Martin F. Jackson, and WCAS for $16.50 per share in cash, representing an enterprise value of $3.9B and premiums of 18% over the unaffected share price and 25% over the 90-day VWAP as of November 24, 2025. The transaction, unanimously approved by a special committee of independent directors, is expected to close mid-2026 subject to majority non-consortium shareholder approval, HSR antitrust clearance, and other regulatory approvals, with initial rollover participants owning 11.8% agreeing to vote in favor. While offering a significant premium, the deal carries risks including failure to secure approvals, potential termination fees, business disruptions, and stock price decline if not consummated.

• ·As of Dec 31, 2025, Select Medical had operations in 39 states and the District of Columbia.
• ·Merger not subject to financing condition; existing debt expected to remain outstanding.
• ·Advisors include Goldman Sachs and Skadden Arps (Special Committee), J.P. Morgan and Wells Fargo (Consortium debt financing), Dechert LLP (Select Medical).

03-03-2026

EVgo Inc. reported record Q4 2025 total revenue of $118M, up 75% YoY, and FY 2025 revenue of $384M, up 50% YoY, with charging network revenue hitting $64M in Q4 (+37% YoY) and $218M for the year (+40% YoY); network throughput grew 18% YoY to 99 GWh in Q4 and 32% to 366 GWh FY. The company achieved positive Adjusted EBITDA of $25M in Q4 and $12M FY, a milestone, but reported net losses of $11M Q4 (improved 69% YoY) and $95M FY (improved 25% YoY), alongside high GAAP capex of $49M Q4 (+108% YoY) and FY operating cash flow slightly negative at -$8M. 2026 guidance projects revenue of $410-470M but Adjusted EBITDA of -$20M to $20M, signaling potential flat or declining profitability.

• ·EVgo public network stalls: 3,890 as of Dec 31, 2025 (+13% YoY)
• ·EVgo dedicated network stalls: 140 (+27% YoY)
• ·EVgo eXtend™ stalls: 1,070 (+106% YoY)
• ·Q4 gross margin: 38.0% (+2,350 bps YoY); FY: 21.0% (+960 bps YoY)
• ·Autocharge+ accounted for 30% of Q4 charging sessions
• ·PlugShare: 7.8M registered users, 10.1M check-ins since inception
• ·2026 guidance: Total revenue $410M-$470M; Adjusted EBITDA -$20M to $20M

03-03-2026

PMGC Holdings Inc. (ELAB) consummated Secured Pre-Paid Purchase #4 on February 6, 2026, under its existing equity purchase facility, with an original principal of $8.1M and purchase price of $7.5M, funded via allocations including $6.3M to a new subsidiary's controlled deposit account, $0.65M to placement agent Univest Securities LLC, $5K in legal fees, and $0.5M to the Company. The Investor can require issuance of Purchase Shares at 88% of the lowest VWAP over the prior 10 trading days (or cash if below $0.32), subject to a 9.99% ownership cap, with Company prepayment option at 120% and default penalties including 15% increase and 18% interest. A portion of Purchase Shares worth $1.2M was registered via prospectus supplement filed February 17, 2026.

• ·Deposit Account Control Agreement (DACA) grants Investor first-position security interest and control over funds upon instruction.
• ·Events of Default include failure to pay, insolvency, bankruptcy, judgments over $1M, and breaches of covenants.
• ·Equity facility originated from Securities Purchase Agreement dated September 23, 2025 (disclosed in 8-K filed September 29, 2025).

03-03-2026

Compass Diversified Holdings (CODI) elected Eugene Kim and Glenn Richter to its Board of Directors effective March 1, 2026, increasing the board size from seven to eight following Alexander S. Bhathal's resignation on February 28, 2026, due to other commitments. Kim, with over 25 years in private equity and investment banking, joins the Audit and Compensation Committees, while Richter, a former CFO of International Flavors & Fragrances Inc. and other major firms, joins the Audit and Nominating & Corporate Governance Committees. Company leadership expressed enthusiasm for their expertise in transactions, finance, operations, and transformations to support long-term value creation.

• ·Mr. Kim previously served as Managing Director at Compass Partners International and held roles at Goldman Sachs International and UBS/Warburg Dillon Read.
• ·Mr. Richter served as Senior Executive Vice President and CFO at TIAA, and CFO at RR Donnelley and Sears Roebuck & Co.
• ·Annual Report on Form 10-K for year ended December 31, 2025 filed with SEC on February 27, 2026.

03-03-2026

Mayville Engineering Company (NYSE: MEC) reported Q4 2025 net sales of $134.3 million, up 10.7% YoY due to the Accu-Fab acquisition, strong growth in Data Center & Critical Power (from $4.3M to $20.4M), Construction & Access (+13.1%), and Powersports (+19.7%), but declines in Commercial Vehicle (-18.6% to $38.4M) and Military (-9.9% to $6.7M), with Agriculture flat at $7.7M. Adjusted EBITDA fell to $6.3 million (4.7% margin) from $9.2 million (7.6%), reflecting project launch costs and inefficiencies, resulting in a net loss of $4.4 million. For full-year 2025, net sales declined 6.0% to $546.5 million with a net loss of $8.1 million, though Adjusted EBITDA was $47.1 million (8.6% margin); FY 2026 guidance anticipates sales of $580-620 million and Adjusted EBITDA of $50-60 million amid ongoing legacy market softness.

• ·Q1 2026 guidance: Net sales $137-143M (vs Q1 2025 $135.6M), Adjusted EBITDA $5-7M (vs $12.2M)
• ·FY 2026 guidance: Free Cash Flow $25-35M, capex $15-20M
• ·Net debt to TTM Adjusted EBITDA ratio 3.7x as of Dec 31, 2025
• ·Accu-Fab expected to generate $40-50M incremental revenue in 2026
• ·Conference call scheduled for March 4, 2026 at 10:00 a.m. ET

03-03-2026

i3 Verticals, Inc. held its 2026 Annual Meeting of Stockholders on March 3, 2026, with 28,382,815 shares present, representing 91.6% of outstanding Common Stock as of the January 2, 2026 record date. All eight director nominees were elected with strong majorities (For votes ranging from 24.4M to 26.0M), though Elizabeth Seigenthaler Courtney received the highest withheld votes at 1,785,903; Deloitte & Touche LLP was ratified as auditors for the fiscal year ending September 30, 2026 with near-unanimous support (99.5% For); and executive compensation was approved on an advisory basis (98.3% For).

• ·Director vote details: Gregory Daily (For: 25,967,528; Withheld: 215,367); Clay Whitson (For: 26,011,532; Withheld: 171,363); Elizabeth Seigenthaler Courtney (For: 24,396,992; Withheld: 1,785,903); John Harrison (For: 25,443,942; Withheld: 738,953); Decosta Jenkins (For: 26,019,856; Withheld: 163,039); Timothy McKenna (For: 25,827,859; Withheld: 355,036); David Morgan (For: 25,431,093; Withheld: 751,802); David Wilds (For: 25,985,663; Withheld: 197,232)
• ·Auditor ratification: Against 145,375; Abstain 604
• ·Say-on-pay: Against 442,168; Abstain 3,317

03-03-2026

On February 27, 2026, The Walt Disney Company entered into a new 364-Day Credit Agreement for up to $5.25B (replacing the February 28, 2025 facility) and a new Five-Year Credit Agreement for up to $4B (replacing the March 4, 2022 facility), both unsecured with guarantees from TWDC Enterprises 18 Corp. These facilities support commercial paper borrowings and general corporate purposes, with maturities on February 26, 2027 (extendable to 2028) and February 27, 2031, respectively. An amendment to the March 1, 2024 Credit Agreement excluded FuboTV Inc. as an entity.

• ·Credit Agreements include customary covenants such as financial statement delivery, tax payments, and maintenance of existence; require minimum EBITDA to Interest Expense ratio of 3.00 to 1.00.
• ·Borrowings bear interest at Term SOFR (Dollars), EURIBOR (Euro), TIBOR (Yen), or Daily Simple SONIA (Sterling) plus spread of 0.625%-1.000%, or Base Rate + 0.000%.
• ·Excludes certain entities related to Hong Kong Disneyland, Shanghai Disney Resort, and FuboTV from representations, covenants, or events of default.
• ·Advances may be prepaid without penalty (except breakage costs); mechanism to replace benchmarks if unavailable.

03-03-2026

Inno Holdings Inc. (INHD) held its virtual 2026 Annual Stockholders Meeting on March 2, 2026, with 4,660,788 shares represented, achieving a 55.40% quorum of the 8,413,224 outstanding shares as of the February 5 record date. All six proposals passed overwhelmingly, including the election of directors Ding Wei, Mengshu Shao, Yufang Qu, Tao Tu, and Yongbo Mo; ratification of JWF Assurance PAC as auditor for FY ending September 30, 2026; increasing authorized common shares to 1,000,000,000; authorizing board discretion for reverse stock splits (1-for-2 to 1-for-4000 within 2 years); approving the 2026 Omnibus Incentive Plan; and adjournment authority.

• ·Proposal 2 (auditor ratification): 4,540,787 For (89.0% of votes cast), 50,651 Against, 69,349 Abstentions.
• ·Proposal 3 (increase authorized shares): 4,476,419 For (96.1% of votes cast), 178,586 Against, 5,781 Abstentions.
• ·Proposal 4 (reverse split authority): 4,481,647 For (96.1% of votes cast), 172,918 Against, 6,221 Abstentions.
• ·Proposal 5 (Omnibus Incentive Plan): 4,486,587 For (96.3% of votes cast), 166,621 Against, 7,579 Abstentions.

03-03-2026

Versus Systems Inc. announced the renewal of its partnership with the Texas Rangers for the Filter Fan Cam product, extending through the 2026 Major League Baseball season and building on a successful five-year collaboration. The agreement introduces next-generation enhancements, including a high-performance C++ tracking engine, 60 frames per second camera driver, improved facial tracking, and dynamic face paint filters to boost fan engagement and create revenue opportunities. No financial terms or metrics were disclosed.

• ·Deployment at Globe Life Field during Texas Rangers home games.
• ·Filing date: March 3, 2026

03-03-2026

Viper Energy, Inc. filed an 8-K on March 3, 2026, providing an updated unaudited pro forma condensed combined statement of operations for the year ended December 31, 2025, giving effect to the Sitio Acquisition (consummated August 19, 2025) and Endeavor Drop-Down (consummated May 1, 2025) as if each occurred on January 1, 2025. The filing also includes a press release dated March 2, 2026, announcing the launch of a secondary common stock offering by Diamondback Energy, Inc., EnCap Energy Capital Fund X, L.P., and Tumbleweed Royalty IV, LLC. No specific financial metrics from the pro forma are detailed in the filing body.

• ·Sitio Acquisition agreement dated June 2, 2025; amended 8-K on August 25, 2025
• ·Endeavor Drop-Down agreement dated January 30, 2025; prior 8-K filed May 5, 2025
• ·Exhibit 99.1: Press release dated March 2, 2026
• ·Exhibit 99.2: Pro forma for year ended December 31, 2025

03-03-2026

Skyworks Solutions CEO Phil Brace highlighted strong execution with four consecutive quarters of beat and raise, trajectory improvement in content at largest customer Apple, and the historic Qorvo acquisition enhancing GaN and RF capabilities for long-term growth in wireless tech through 2030. However, he noted ongoing challenges including flattish Apple content (stabilization rather than growth), prior loss of half a key socket to Broadcom, inflationary input costs like gold and PCBs, and external overhangs such as memory shortages and tariffs. Overall, Brace expressed optimism tempered by caution, emphasizing technology leadership amid a hyper-competitive market.

• ·Skyworks maintaining low inventory and monitoring book-to-bill amid potential memory shortages.
• ·No price concessions requested by smartphone customers despite memory cost pressures.
• ·Apple shifting to internal modem platform, providing ecosystem clarity.

03-03-2026

Flowco Holdings Inc. (NYSE: FLOC) completed its acquisition of Valiant Artificial Lift Solutions, LLC on March 3, 2026, for total consideration of approximately $200 million net of Valiant's cash, comprising $170 million in net cash funded by its ABL facility and 1.5 million shares of Class A common stock. The deal enhances Flowco's artificial lift portfolio with Valiant's ESP capabilities, enabling earlier well support and expanded presence in the Permian and other basins. CEO Joe Bob Edwards emphasized the cultural alignment and strategic synergies for delivering optimized solutions.

• ·Funded using available capacity under ABL facility
• ·Share amount originally determined based on 10-day volume-weighted average price as of January 30, 2026
• ·References Risk Factors in Form 10-K for fiscal year ended December 31, 2025

03-03-2026

Limbach Holdings, Inc. reported record FY2025 revenue of $646.8M, up 24.7% YoY from $518.8M, with ODR revenue surging 40.6% to $485.7M (75.1% of total) and adjusted EBITDA rising 28.4% to $81.8M; Q4 revenue hit a record $186.9M (+30.1% YoY). However, GCR revenue declined 7.0% YoY to $161.1M for the year and 13.0% to $41.9M in Q4, total gross margin fell to 26.2% from 27.8%, and ODR gross margin dropped to 26.7% due to the Pioneer Power acquisition. The company announced a $50M share repurchase program and provided 2026 guidance of $730M-$760M revenue and $90M-$94M adjusted EBITDA.

• ·Q4 2025 gross margin declined to 25.7% from 30.3% YoY; ODR gross margin fell to 25.1% from 32.1% due to Pioneer Power integration.
• ·FY2025 total organic revenue growth was 3.6%; ODR organic growth 17.0%.
• ·2026 guidance: Revenue $730M-$760M, Adjusted EBITDA $90M-$94M, ODR organic growth 9-12%, gross margin 26-27%.
• ·Acquisitions contributed $109.1M to FY2025 revenue growth.
• ·Net cash from operations: Q4 $28.1M (vs $19.3M), FY $45.7M (vs $36.8M).

03-03-2026

Atlantic Union Bankshares Corporation filed an 8-K on March 3, 2026, under Items 7.01 and 9.01, furnishing an updated investor handout (Exhibit 99.1) for use by management in meetings with investors, analysts, and other parties during Q1 2026. The handout is available on the company's Investor Relations website at https://investors.atlanticunionbank.com. No specific financial metrics or performance data were disclosed in the filing.

• ·Filing intended to satisfy Regulation FD Disclosure requirements.
• ·Securities registered on New York Stock Exchange: Common Stock (AUB) and Depositary Shares (AUB.PRA).

03-03-2026

Leidos, Inc., a subsidiary of Leidos Holdings, Inc. (LDOS), issued $600M of 4.100% senior notes due 2029 and $800M of 5.000% senior notes due 2036, generating approximately $1,387M in net proceeds to fund a portion of the proposed acquisition of ENTRUST pursuant to the January 23, 2026 Stock Purchase Agreement. The notes are senior unsecured obligations guaranteed by Leidos Holdings, with interest payable semi-annually starting September 15, 2026, and include special mandatory redemption at 101% if the acquisition is not completed by August 14, 2026 or later extended date. The issuance is not conditioned on the acquisition closing.

• ·Notes issued under October 2020 Indenture supplemented by officers’ certificate dated March 2, 2026.
• ·Early redemption with make-whole premium before Feb 15, 2029 (2029 Notes) or Dec 15, 2035 (2036 Notes); par redemption thereafter.
• ·Change of control repurchase offer at 101% of principal.
• ·Acquisition Agreement dated January 23, 2026; End Date August 14, 2026.

03-03-2026

Chiron Real Estate LP (Issuer) and Chiron Real Estate Inc. (Parent), affiliates of Global Medical REIT Inc., entered into a Master Note and Guaranty Agreement dated March 2, 2026, with NYL Investors LLC and New York Life affiliates, establishing an uncommitted facility for issuing senior promissory notes in series with aggregate principal not exceeding the Available Facility Amount. Notes can be requested in minimum increments of $10M, with maturities and average lives up to 10 years, during an Issuance Period of up to three years. The facility provides flexible access to capital without current obligations or draws.

• ·Issuance Period extends until the earlier of the third anniversary of March 2, 2026, or other termination events.
• ·Individual Notes mature no more than 10 years from issuance date with average life no more than 10 years.
• ·Facility is explicitly uncommitted; New York Life has no obligation to purchase Notes or quote spreads.

03-03-2026

Honeywell International Inc. announced on March 3, 2026, the filing of a Form 10 registration statement by its wholly owned subsidiary, Honeywell Aerospace Inc., with the SEC in connection with the anticipated spin-off of its Aerospace business into an independent, publicly traded company. A press release detailing the announcement is furnished as Exhibit 99.1. The filing includes extensive cautionary language on forward-looking statements, highlighting risks such as potential delays, failure to complete the Spin-Off, disruptions to operations, and uncertain financial impacts post-separation.

03-03-2026

Kontoor Brands reported Q4 2025 revenue of $1.02B, up 46% YoY driven by 36pp from Helly Hansen acquisition, though excluding HH and 53rd week it grew only 2%; full-year revenue reached $3.15B, up 21% YoY including 18pp from HH, with Wrangler up 6% but Lee down 5%. Adjusted EPS rose 26% to $1.73 in Q4 and 14% to $5.59 FY, with gross margins expanding; 2026 outlook projects revenue growth of 9% to $3.40-3.45B and adjusted EPS up 15-16% to $6.40-6.50, tempered by tariff increases. The company reduced inventory 26% QoQ to $567M, made a $200M debt payment, and repurchased $25M in shares.

• ·Lee international revenue decreased 6% YoY in Q4.
• ·Adjusted operating income ex Helly Hansen increased 9% YoY in Q4 to $110M.
• ·Pro-forma net leverage ratio at 2.0x end Q4.
• ·Quarterly dividend $0.53/share, payable March 20, 2026.
• ·$190M remaining under share repurchase authorization.
• ·2026 outlook assumes 15% tariff on new inventory receipts and 20% on pre-Feb 24 inventory.
• ·Cash from operations 2026 expected ~$425M; capex $45M.

03-03-2026

Versant Media Group reported full-year 2025 revenue of $6.69B, down 5.3% YoY from $7.06B amid declines in linear distribution (-5.4%), advertising (-8.9%), and content licensing (-8.5%), while platforms grew 3.9%. Net income attributable to Versant dropped 31.8% to $930M and Adjusted EBITDA fell 14.5% to $2.42B from prior year levels. The company announced a $0.375 per share quarterly cash dividend (payable April 22, 2026) and a Board-approved $1B share repurchase authorization.

• ·Acquired Free TV Networks in January 2026 and INDY Cinema Group in Q4 2025.
• ·Net cash provided by operating activities $2.02B in 2025, down from $2.21B in 2024.
• ·Conference call scheduled for March 3, 2026, at 8:00 a.m. ET.

03-03-2026

Advantage Solutions Inc. reported Q4 2025 revenues of $932.1M, up 4.5% YoY, driven by strong 21.6% growth in Experiential Services, but full-year revenues declined 0.7% to $3.54B amid 10.9% drop in Branded Services. Adjusted EBITDA decreased 7.3% to $87.7M in Q4 and 6.8% to $331.8M for the year, reflecting declines across Branded (down 29.1% Q4) and Retailer Services (down 22.5% Q4), partially offset by Experiential's 114.8% Q4 surge. The company ended with $241M cash (up ~$40M sequentially), ~$55M from divestitures, and anticipates flat to low-single-digit revenue growth and flat to down mid-single-digit Adjusted EBITDA in 2026.

• ·Net Leverage Ratio: 4.4x as of Dec 31, 2025
• ·FY 2026 Outlook: Adjusted Unlevered Free Cash Flow $250-275M; Net Interest Expense $160-170M; Capex $50-60M
• ·Conference call: March 3, 2026, 8:30 am EDT

03-03-2026

908 Devices Inc. reported Q4 2025 revenue of $17.4M, up 21% YoY, and full-year 2025 revenue of $56.2M, up 18% YoY, with positive Adjusted EBITDA of $0.7M in Q4 but a full-year Adjusted EBITDA loss of $9.6M and net loss from continuing operations of $33.3M. Recurring revenue grew 22% YoY to $19.5M (35% of total), installed base expanded 24% to 3,736 devices, and cash position strengthened to $113.0M; however, GAAP gross margin remained flat at 51% for the full year. The company guides for 2026 revenue of $64.5M-$67.5M, implying 15-20% growth.

• ·OEM and funded partnership revenue: $1.0M in Q4 2025 (vs $0.7M Q4 2024); $3.0M FY 2025 (vs $1.6M FY 2024)
• ·Recurring revenue: 32% of Q4 2025 total revenue (vs 35% FY)
• ·Operating expenses Q4 2025: $6.1M (down from $23.4M Q4 2024 due to one-time items including goodwill impairment and contingent consideration changes)
• ·2026 revenue guidance: $64.5M to $67.5M

03-03-2026

Roivant Sciences Ltd. announced via press release that the U.S. FDA has accepted the New Drug Application (NDA) for brepocitinib, filed by its subsidiary Priovant Therapeutics, for the treatment of dermatomyositis and granted Priority Review. This regulatory milestone advances the potential approval timeline for the drug. No financial or comparative performance data was disclosed.

• ·Filing date: March 3, 2026
• ·Press release date: March 3, 2026
• ·U.S. FDA granted Priority Review to the NDA

03-03-2026

Ziff Davis, Inc. entered into a Securities Purchase Agreement on March 2, 2026, to sell its Connectivity division to Accenture Inc. for an aggregate purchase price of $1.2 billion in cash, subject to customary adjustments and regulatory approvals. The transaction closing is uncertain due to required approvals and other conditions, as highlighted in forward-looking statements noting risks such as economic downturns and regulatory hurdles. A press release was issued on March 3, 2026, with full details to be provided in a separate 8-K filing.

• ·Filing includes Exhibit 99.1: Press Release dated March 3, 2026.
• ·Separate Current Report on Form 8-K will provide additional information on the Purchase Agreement.
• ·Registrant details: Delaware incorporation, Commission File Number 0-25965, I.R.S. Employer Identification No. 47-1051457, principal offices at 360 Park Ave S., 17th Floor, New York, New York 10010.

03-03-2026

Civeo reported Q4 2025 revenues of $161.6M, up 7% YoY from $151.0M, with Adjusted EBITDA rising 90% to $21.7M, driven by Australian growth (+9% revenues) and Canadian margin improvement (from -13% to 8%). However, full-year 2025 revenues declined 6% YoY to $638.8M from $682.1M amid Canadian occupancy pressures, resulting in a wider net loss of $20.1M versus $17.1M in 2024, despite Adjusted EBITDA growth to $88.2M (+10% YoY). The company repurchased 2.3M shares for $53.6M (17% of shares outstanding), nearing completion of its initial 20% repurchase authorization, and announced a new 10% authorization.

• ·Full year 2026 guidance: revenues $650M-$700M, Adjusted EBITDA $85M-$90M, capex $25M-$30M.
• ·Net leverage ratio of 1.9x as of Dec 31, 2025.
• ·Q4 2025 free cash flow $15.3M (vs $2.1M in Q4 2024).
• ·Conference call scheduled for March 3, 2026 at 11:00 a.m. ET.

03-03-2026

On March 2, 2026, Innventure, Inc. executives Michael Otworth and John Scott filed Form 4s disclosing the withholding of shares to cover tax obligations on vested RSUs settled on February 26, 2026. This non-discretionary transaction complied with Rule 16b-3 and award terms, with no open-market sales involved. Post-settlement, Otworth beneficially owns 3,274,030 shares and Scott owns 1,814,998 shares, indicating continued alignment with shareholders.

• ·Form 4 filings occurred on March 2, 2026, for RSU settlement on February 26, 2026.
• ·Withholding based on closing price of common stock on settlement date.
• ·Transaction exempt from Section 16(b).

03-03-2026

PEDEVCO Corp. announced that its board of directors approved a 1-for-20 reverse stock split of its common stock. The reverse split is expected to become effective at 12:01 AM ET on March 13, 2026, with trading on a post-split basis beginning on the NYSE American at market open on the same day under the unchanged ticker 'PED' but with a new CUSIP number 70532Y402. No fractional shares will be issued; instead, holders will receive cash payments in lieu based on the closing price prior to the effective time.

• ·No change in trading symbol 'PED' post-split.
• ·Cash in lieu of fractional shares calculated as fraction multiplied by closing price on trading day before effective time.
• ·Information furnished under Item 7.01 is not 'filed' and not subject to liabilities under Section 18 of the Exchange Act.

03-03-2026

Theravance Biopharma's Phase 3 CYPRESS study for ampreloxetine failed to meet its primary endpoint (OHSA Composite Score), leading to the program's wind down, while YUPELRI net sales grew 12% YoY to $266.6M in FY2025 and 6% YoY to $70.6M in Q4 2025. The company holds $326.5M cash at Q4 2025 (no debt), expects ~$400M by end-Q1 2026 including recent milestones, and anticipates $60-70M annualized cash flow from Q3 2026 after 60% cost reductions (~$70M savings from 2025's ~$110M opex). The Strategic Review Committee is accelerating evaluation of alternatives, including a potential sale, to maximize shareholder value.

• ·Restructuring impacts ~50% of workforce, including full R&D wind down and 50% G&A cut, over next two quarters.
• ·YUPELRI co-promotion: 65% profit/loss to Viatris, 35% to Theravance.
• ·TRELEGY milestones from Royalty Pharma triggered by GSK global net sales thresholds.
• ·$2.6B Irish tax attributes.
• ·Preliminary financials subject to change in upcoming 10-K.

03-03-2026

Sportsman’s Warehouse Holdings, Inc. reported preliminary FY2025 net sales of $1,209.2 million, up 1.0% YoY, with same-store sales also increasing 1.0% to $1,205.6 million, marking the first positive full-year SSS growth since 2020, alongside Adjusted EBITDA of $27.5 million. The balance sheet improved with ending inventory down $29.1 million or 8.5% to $312.9 million, net debt down 6.1% to $90.0 million, free cash flow of $7.6 million, and total liquidity of $107.8 million. However, the company identified approximately five underperforming stores for potential closure, contributing about -$1.5 million to FY2025 Adjusted EBITDA, and expects impairment charges related to leasehold improvements and operating lease assets.

• ·Q4 Adjusted EBITDA of approximately $9.6 million.
• ·Full FY2025 financial results to be reported on March 31, 2026.
• ·Preliminary results subject to change upon completion of year-end accounting and audit.

03-03-2026

MVB Financial Corp., holding company for MVB Bank Inc., redeemed all $40.0 million aggregate principal amount of its 4.25% Fixed-to-Floating Rate Subordinated Notes due 2030 on March 2, 2026, which qualified as Tier 2 capital and bore 7.67% interest at redemption. The redemption was funded by a $20.0 million draw on its revolving line of credit and cash on hand. No other period-over-period metrics or performance changes were reported.

• ·Redemption date: March 2, 2026; Filing date: March 3, 2026
• ·Notes structured to qualify as Tier 2 capital for regulatory purposes

03-03-2026

Safe Harbor reported 29% YoY growth in emerging US cannabis markets' average deposit balances over the 12 months ended February 4, 2026, now representing 31% of total average deposit balances, driven by over 100 new customer depository accounts and strategic entry into high-growth states. However, total average deposit balances grew more modestly at 4.5% YoY. The company has facilitated more than $26B in cannabis-related transactions across 41 states and territories.

• ·Emerging markets include: New Markets Coming Online (Delaware, Minnesota, Kentucky, Alabama, Mississippi); Licensing Expansion (New York, New Jersey, Maryland, Connecticut, Missouri, Ohio); Operator Footprint Expansion (Pennsylvania, Illinois, Virginia, Florida).
• ·Average deposit balances defined as trailing 14-day average daily deposit balances at financial institution partners.
• ·Emerging US markets defined as states with cannabis programs launched or materially expanded within the past five years.

03-03-2026

Aphoenity International Holdings Inc. (formerly Luduson G Inc., ticker LDSN) changed its domicile from Delaware to Wyoming via statutory conversion on July 21, 2025, with continuity of assets, liabilities, and securities. Effective October 1, 2025, the company name changed to Aphoenity International Holdings Inc., and on November 18, 2025, it implemented a 1,000-for-1 reverse stock split (with fractional shares rounded up) and updated its EIN to 98-1872097, while maintaining par value at $0.0001 per share.

• ·Trading symbol: LDSN (OTC)
• ·CIK: 0001737193
• ·SIC: 7374 (Services-Computer Processing & Data Preparation)
• ·Principal address: 35/F, Central Plaza, 18 Harbour Road, Wanchai, Hong Kong
• ·Phone: +852 2824 8560

03-03-2026

Cullen/Frost Bankers, Inc. filed an 8-K/A on March 3, 2026, amending its February 11, 2026 8-K under Item 7.01 to replace the initial investor presentation with an updated version as of December 31, 2025. The revisions add information on the company's technology strategy, update peer data, and correct certain items from the original exhibit. No specific financial metrics or performance changes are disclosed in the filing.

• ·Presentation available at https://investor.frostbank.com
• ·References most recent 10-K filed February 5, 2026

03-03-2026

MainStreet Bancshares, Inc. announced on March 3, 2026, that it repurchased 174,280 shares of its common stock since the beginning of 2026 at an average price of $22.45 per share under its ongoing stock repurchase program, conducted in compliance with Rule 10b-18. This repurchase price was below the company's tangible book value of $25.52 per share as of December 31, 2025. The program does not obligate further repurchases and may be modified or terminated at any time.

• ·Repurchases conducted in accordance with Rule 10b-18 and other applicable legal requirements

03-03-2026

A shareholder in COCA-COLA EUROPACIFIC PARTNERS plc (CCEP) has crossed or reached a threshold, resulting in a holding of 37.07% of voting rights attached to shares (with 0% through financial instruments), equivalent to 166,128,987 total voting rights. No position from previous notification is provided, indicating this may be a new or significantly updated stake.

• ·Filing date: March 03, 2026
• ·Filing type: 6-K (Foreign Issuer Report)

03-03-2026

On March 3, 2026, BARK, Inc. filed an 8-K announcing that Matt Meeker, its Chief Executive Officer and Executive Chair of the Board, voluntarily withdrew from participation as a member in Great Dane Ventures, LLC. The announcement was made via a press release attached as Exhibit 99.1. No financial impacts or further details on implications were disclosed.

03-03-2026

In ongoing receivership proceedings for Global Tech Industries Group, Inc. appointed on September 18, 2024, the court-approved receiver Paul L. Strickland finalized a confidential settlement agreement with former President and Director Kathy Griffin and family members on December 22, 2025, with court approval on February 26, 2026. Separately, the Company's wholly-owned subsidiary TTII Strategic Acquisitions & Equity Group Inc. obtained a default judgment against Astra Energy, Inc. on March 2, 2026, following a complaint filed on July 22, 2025. These legal resolutions address prior disputes but occur under court-supervised receivership, with no financial details disclosed.

• ·Receivership case: White Rocks (BVI) Holdings Inc., et al., v. Reichman, et al., Case No.: A-24-896359-B, Clark County, Nevada District Court
• ·Exhibits include Order 99.1 approving Griffin settlement and 99.2 for ASRE judgment

03-03-2026

Global Arena Holding, Inc. (Parent) and its wholly-owned subsidiary Global Election Services, Inc. (GE Services) entered into an Asset Purchase Agreement dated February 26, 2026, with GES Acquisition Corp. and Easterly CV VI LLC, to sell substantially all assets of their technology-enabled election services business (including fixed assets, contracts, IP, receivables, and goodwill), excluding cash and certain other items. Consideration consists of $2.4M cash payable to GE Services and 2,571,428 shares of GES Acquisition common stock issued to Parent, with GES Acquisition assuming only specified post-closing liabilities. No financial performance metrics or period-over-period comparisons are provided in the agreement.

• ·Assets exclude cash, cash equivalents, tax returns, insurance policies, and non-assumed contracts.
• ·Assumed Liabilities limited to post-Effective Time obligations under Assumed Contracts, IP, and Permits.
• ·Exhibits include Certificate of Designations for Series A Convertible Preferred Stock, Promissory Note, Employment Agreements, NDA/IP Rights Agreement, and Bill of Sale.

03-03-2026

Intel Corporation announced that Frank Yeary, Chair of the Board, intends to retire effective upon the conclusion of the 2026 Annual Meeting of Stockholders, with the Board size reducing from 12 to 11 directors. Dr. Craig H. Barratt was named as the new Chair effective the same date. The announcement was made via a press release dated March 3, 2026, following Yeary's notification to the Board on February 27, 2026.

• ·Filing date: March 3, 2026
• ·Date of earliest event reported: February 27, 2026
• ·Press release titled: 'Intel Board Chair Frank D. Yeary to Retire Following Annual Meeting; Dr. Craig H. Barratt Elected as Chair'

03-03-2026

Arcturus Therapeutics reported Q4 and FY 2025 financial results with revenue declining sharply to $7.2M (-68%) and $82.0M (-46%) YoY, respectively, due to lower CSL collaboration activity, though operating expenses fell more significantly to $38.5M (-31%) and $158.3M (-36%) YoY, narrowing net losses to $29.1M and $65.8M. Cash position stood at $232.8M, extending runway into Q2 2028 amid disciplined cost management. Pipeline progressed positively with ARCT-032 cleared for 12-week Phase 2 study in H1 2026 and ARCT-810 regulatory meetings on track for H1 2026, but R&D expenses remained elevated at $112.2M for FY despite YoY decline.

• ·Lawsuit against AbbVie Inc. and Capstan Therapeutics, Inc. filed September 23, 2025, remains ongoing.
• ·UK MHRA granted approval for KOSTAIVE® in January 2026 for individuals aged 18+.
• ·Investor conference call held March 3, 2026 at 4:30 p.m. ET.

03-03-2026

CrowdStrike reported Q4 FY26 total revenue of $1.31B, up 23% YoY from $1.06B, and ending ARR of $5.25B, up 24% YoY with record net new ARR of $331M (+47% YoY); full year revenue grew 22% YoY to $4.81B with record non-GAAP net income of $957M and free cash flow of $1.24B. However, full year GAAP operating loss widened to $293M from $116M prior year, and GAAP net loss increased to $163M from $15M. The company announced acquisitions of SGNL and Seraphic Security, repurchased $51M in shares, and raised FY27 ARR guidance to $6.47B-$6.52B.

• ·Subscription gross margin GAAP 79% Q4 FY26 (up from 77% YoY), non-GAAP 81% (up from 80%).
• ·Q4 GAAP net income $38.7M vs loss of $86.3M YoY; non-GAAP net income $289.1M (up from $205.3M).
• ·FY27 guidance: Q1 ARR $5.50B-$5.50B, total rev $1.36B-$1.36B; FY ARR $6.47B-$6.52B.
• ·100% detection and protection in 2025 MITRE ATT&CK Evaluations.
• ·Forrester TEI study: 273% ROI for customers replacing legacy endpoint security.
• ·New regional cloud deployments planned for Saudi Arabia, India, UAE.

03-03-2026

PennantPark Investment Corporation (PNNT) filed an 8-K on March 3, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01, announcing its monthly distribution via a press release furnished as Exhibit 99.1. No specific details on the distribution amount or performance metrics were provided in the filing. The announcement is not deemed 'filed' and includes standard forward-looking statement disclaimers.

• ·Common Stock, par value $0.001 per share, traded as PNNT on the New York Stock Exchange.
• ·Principal executive offices: 1691 Michigan Avenue, Miami Beach, Florida 33139.

03-03-2026

VSEE Health, Inc. held a special stockholder meeting on March 2, 2026, achieving quorum with 50.46% participation (21,824,877 votes out of 43,400,255 entitled). Stockholders approved Proposal 1, authorizing issuance of up to 19,672,130 common shares upon warrant exercise per Nasdaq Rule 5635(d), with 14,109,726 FOR and 7,698,963 AGAINST votes. Proposal 2 to adjourn the meeting was approved (18,629,017 FOR) but withdrawn as unnecessary.

• ·Record date for Special Meeting: February 2, 2026
• ·Proxy statement filed February 5, 2026, supplemented February 17, 2026
• ·Total votes entitled: 43,244,355 (common) + 155,900 (preferred) = 43,400,255

03-03-2026

On February 27, 2026, the Boards of Northpointe Bancshares, Inc. and its subsidiary Northpointe Bank received notices from directors R. Jeffrey Dean, Bruce L. Edger, and John M. Eggemeyer III of their intention to retire at the end of their current terms, expiring at the 2026 Annual Meeting of Stockholders, and they will not stand for reelection. Their decisions are not due to any disagreements with the Company on operations, policies, or practices. The Company expressed appreciation for their service, with Mr. Dean serving since 1999, Mr. Edger since 2005, and Mr. Eggemeyer since 2019.

• ·Mr. Dean serves on Audit Committee, Compensation Committee, and Corporate Governance and Nominating Committee.
• ·Mr. Edger serves on Compensation Committee and Corporate Governance and Nominating Committee.
• ·Mr. Eggemeyer serves on Audit Committee, Compensation Committee, and Corporate Governance and Nominating Committee.
• ·Directors will continue service through the 2026 Annual Meeting of Stockholders.

03-03-2026

China Pharma Holdings, Inc.'s (CPHI) wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd (Helpson), entered into a Technology Transfer Agreement on February 26, 2026, acquiring the Invention Patent for Prinsepia Utilis Esterol Sublingual Tablets and Method for Its Preparation (Patent No. 2018102273158) from Xiaoyan Zhang for $6.93M, payable in 12,600,000 restricted common shares at $0.55 per share. The agreement also includes technical services for product R&D, registration materials, and applications. Shares are issued under Regulation S exemption to a non-U.S. person.

• ·Patent No. 2018102273158, granted March 19, 2018, valid until March 19, 2038.
• ·Technical services include product R&D, registration materials preparation, and application filing.
• ·Issued under Regulation S exemption for offshore transaction to non-U.S. person.

03-03-2026

Selling stockholders, including KKR Phoenix Aggregator L.P. and certain management members, are offering 20,000,000 shares of BrightSpring Health Services, Inc. common stock at $41.15 per share, for total gross proceeds of approximately $823M; the company will not receive proceeds except from any cash exercises of stock options by management sellers. Concurrently, subject to offering completion, the company intends to repurchase 1,464,807 shares from the underwriter at $40.961 per share, with no underwriting discount on those shares and the repurchase not conditioning the offering. On March 2, 2026, the stock closed at $41.58 per share on Nasdaq.

• ·Prospectus supplement dated March 2, 2026; expected share delivery on or about March 4, 2026.
• ·Nasdaq symbol: BTSG; closing price March 2, 2026: $41.58 per share.

03-03-2026

Evolus reported fourth quarter 2025 total net revenue of $90.3 million, up 14% YoY, and full-year 2025 revenue of $297.2 million, up 12% YoY for the sixth consecutive year of double-digit growth, with Q4 achieving GAAP operating income of $4.2 million. However, full-year GAAP operating loss was $32.7 million, a slight improvement from $34.4 million in 2024, while non-GAAP operating loss widened to $9.4 million from $0.3 million income, reflecting higher non-GAAP operating expenses of $209.7 million versus $185.0 million prior year. For 2026, the company guides revenue growth of 10-13% to $327-337 million but with non-GAAP operating expenses growing 0-3% to $210-216 million.

• ·U.S. account penetration above 55%; customer reorder rates approximately 71%.
• ·Evolysse™ and Estyme® expected to contribute 10-12% of 2026 revenue.
• ·Cash increased to $53.8M as of Dec 31, 2025 from $43.5M at Sep 30, 2025.
• ·Evolysse™ subject to 10% tariff, potential additional 5%; Jeuveau® not impacted by tariffs.
• ·2028 outlook: revenue $450-500M (15-19% 3-year CAGR), adjusted EBITDA margins 13-15%.

03-03-2026

Valuence Merger Corp. I, a SPAC, entered into a convertible promissory note with VMCA Sponsor, LLC for principal up to $1.5M, interest-free, to fund operations prior to an initial business combination. The note matures on the earlier of the business combination closing or liquidation, with repayment limited to funds outside the trust account if no combination occurs, and is convertible at the payee's option into warrants at $1.50 each. No drawdowns have been specified, and the agreement includes standard trust waivers and no-prepayment terms.

• ·Note dated February 27, 2026
• ·Drawdowns funded within 1 business day of request, up to $1.5M total outstanding
• ·Conversion warrants identical to those issued in private placement at IPO
• ·Governed by New York law; no personal liability for Maker's officers/directors
• ·Payee waives claims against trust account

03-03-2026

Ward W. Woods informed Alphatec Holdings, Inc. of his retirement from the Board of Directors, effective February 27, 2026, for personal reasons with no disagreements on operations, policies, or practices; he also served on the Compensation Committee. In connection with his departure, the company entered a Vesting Acceleration Agreement fully vesting his unvested restricted stock units granted on June 11, 2025. The Board reduced its size from eight to seven directors on February 26, 2026.

• ·Vesting Acceleration Agreement filed as Exhibit 10.1
• ·Event reported on February 25, 2026; filing dated March 3, 2026

03-03-2026

Enliven Therapeutics reported positive initial Phase 1b ENABLE trial data for ELVN-001 in 60 heavily pretreated CML patients, achieving cumulative MMR rates of 47% (80 mg QD, n=19) and 69% (60/120 mg QD, n=41), with DMR rates of 16% and 35%, respectively. The company ended 2025 with a strong $463M cash position, providing runway into H1 2029, and plans Phase 3 ENABLE-2 initiation in H2 2026. However, net loss widened to $103.7M for FY2025 from $89.0M in FY2024, driven by R&D expenses up 6% to $85.9M and G&A expenses up 42% to $33.8M.

• ·53% of patients received four or more unique prior TKIs; 67% prior asciminib, 32% prior ponatinib
• ·100% of patients achieving MMR maintained it in both dose cohorts
• ·Mid-2026 additional Phase 1 data presentation and FDA alignment on Phase 3 design
• ·Q4 2025 G&A expenses increased 110% YoY to $13.0M due to CEO transition stock-based compensation

03-03-2026

Plains All American Pipeline, L.P. executed a Third Amendment to its Credit Agreement on February 26, 2026, replacing Plains Midstream Canada ULC (PMCULC) as a borrower with Plains Canada Liquid Pipelines ULC (PCLPULC), while releasing PMCULC from all obligations under the loan documents upon full payment of its outstanding loans and obligations. The amendment was agreed upon by the borrowers, Bank of America, N.A. as Administrative Agent, and multiple lenders including Citibank, N.A., JPMorgan Chase Bank, N.A., and Wells Fargo Bank. No financial terms, commitment amounts, or other quantitative changes to the credit facility were disclosed.

• ·Original Credit Agreement dated August 20, 2021
• ·First Amendment dated August 22, 2022
• ·Second Amendment dated August 19, 2024
• ·Amendment requires satisfaction of conditions including KYC documentation, legal opinions from Richard McGee, Vinson & Elkins LLP, and Cox Taylor, and payment of PMCULC's outstanding obligations

03-03-2026

IBM filed an 8-K on March 3, 2026, under Items 5.03 and 9.01, attaching its bylaws as amended through March 1, 2026. The document details governance procedures including stockholder meetings (annual on the last Tuesday of April, special meetings callable by the Board, Chairman, or holders of at least 25% of shares), Board of Directors powers and composition, executive committees, officers, and other corporate matters. No financial metrics, performance changes, or material alterations to shareholder rights are specified in the filing.

• ·Bylaws originally adopted April 29, 1958
• ·Annual stockholder meeting held on last Tuesday of April each year (or next non-holiday)
• ·Stockholder meeting notice: 10-60 days in advance
• ·Quorum for stockholder meetings: majority of outstanding voting shares
• ·Special meetings limited to business specified in notice

03-03-2026

Black Rock Coffee Bar reported strong Q4 2025 results with total revenue of $53.6M, up 25.3% YoY, same store sales growth of 9.3%, and 12 new stores opened, driving operating income to $1.8M from a $0.1M loss and Adjusted EBITDA up 52.4% to $6.5M. For FY2025, revenue grew 24.5% to $200.3M with SSS up 10.1% and 32 new stores, but operating income declined sharply to $0.9M from $6.0M while net loss widened 130.1% to $16.5M amid higher SG&A expenses at 20.6% of revenue versus 15.7% prior year.

• ·Cash and cash equivalents $28.4M and total debt $26.7M as of Dec 31, 2025; repaid $30.1M under $50M term loan, leaving $19.9M outstanding.
• ·FY2026 outlook: 36 new store openings, total revenue $255-257M, mid-single digit SSS growth, Adjusted EBITDA $33.5-34.5M, CapEx $40-41M.
• ·Conference call on March 3, 2026 at 5:00 p.m. ET; replay available until March 17, 2026.

03-03-2026

Ultra Clean Holdings, Inc. (UCTT) entered into a call option transaction with a Dealer to hedge its issuance of $525M aggregate principal amount of 0.00% Convertible Senior Notes due 2031, with an option for up to an additional $75M. The transaction is confirmed under the 2002 ISDA Equity Derivatives Definitions, with an Indenture dated March 3, 2026, between UCTT and U.S. Bank Trust Company, National Association as trustee. Key option terms include a Strike Price of $84.7450, Cap Price of $104.0725, Free Convertibility Date of December 16, 2030, and Expiration Date of March 15, 2031.

• ·Offering Memorandum dated February 25, 2026
• ·Trade Date: [_____] (to be specified)
• ·Effective Date: Closing date of initial Convertible Notes issuance
• ·Exchange: Nasdaq Global Select Market (symbol UCTT)
• ·Option Style: European
• ·Settlement Method: Default Net Share Settlement

03-03-2026

On March 2, 2026, Covista Inc. (formerly Adtalem Global Education Inc.) amended its credit agreement to incur $510 million in new 2026 Term Loans maturing March 2, 2033, with interest rate margins reduced by 0.50% (Term SOFR + 2.25% with 0.75% floor or ABR + 1.25%). Proceeds refinanced existing term loans and fully redeemed $404.95 million in 5.50% Senior Secured Notes due 2028 at 100% of principal plus accrued interest, satisfying and discharging the related indenture. No declines or flat performance noted in this debt refinancing event.

• ·Redemption notice for Notes sent by Trustee on February 13, 2026.
• ·Original Credit Agreement dated August 12, 2021; Indenture dated March 1, 2021.
• ·2026 Term Loans mature on March 2, 2033.

03-03-2026

On March 3, 2026, Lindblad Expeditions Holdings, Inc. acquired an additional 5% interest in its subsidiary Natural Habitat, Inc. from Ben Bressler, Founder and CEO of Natural Habitat, for $16.6 million, increasing the Company's ownership to 95%. Mr. Bressler retains a 5% noncontrolling interest subject to an existing put/call arrangement under the stockholders' agreement. No financial performance metrics or period comparisons were reported.

• ·Acquisition resulted from exercise of put right by Mr. Bressler pursuant to original stockholders' agreement from prior Natural Habitat acquisition.

03-03-2026

ABVC BioPharma filed its 2025 Form 10-K on March 3, 2026, reporting total assets of $21.06 million as of December 31, 2025, a 179% YoY increase from $7.54 million in 2024, primarily driven by net property and equipment surging to $12.84 million from $0.51 million due to strategic land acquisitions in Taiwan. The company advanced its asset-backed licensing model by licensing CNS, oncology, and ophthalmology programs to subsidiaries AiBtl BioPharma, OncoX BioPharma, and ForSeeCon Eye Corporation, reducing direct clinical burn while retaining economics. No operating results or declines were highlighted, emphasizing balance sheet strengthening.

• ·Research institutions in network: Stanford University, University of California at San Francisco, Cedars-Sinai Medical Center
• ·Longtan land held by related party pending title transfer
• ·Puli land title transfer under government review as of press release date

03-03-2026

On March 2, 2026, Group 1 Automotive, Inc. entered into a Second Amendment to Daryl Kenningham's Incentive Compensation Agreement, restructuring severance benefits to 1.5 times the sum of his base salary and target annual bonus, plus 18 months of COBRA coverage and a pro-rated bonus for qualifying terminations. Benefits increase to 2.0 times the sum and 24 months of COBRA if termination occurs within six months of a Corporate Change. Severance is payable in a lump sum on the first day of the seventh month following separation, subject to compliance with covenants and execution of a release.

• ·Severance benefits are Mr. Kenningham’s sole and exclusive remedy against the Company.
• ·Full Second Amendment to be filed in next Quarterly Report on Form 10-Q.

03-03-2026

Delcath Systems, Inc. announced on March 3, 2026, the publication of CHOPIN clinical trial results in The Lancet Oncology via a press release furnished as Exhibit 99.1. The filing highlights this milestone under Item 8.01 Other Events, signed by CEO Gerard Michel. No financial or quantitative performance data was disclosed.

03-03-2026

Star Equity Holdings, Inc., through its subsidiary Alliance Drilling Tools, LLC, completed a sale and leaseback transaction for property in Evanston, Wyoming, to Pasture Drive Holdings, LLC for $1.7M on February 27, 2026. The company entered into a 20-year triple net lease with initial monthly base rent of $12,390, guaranteed by the parent company, covering all property expenses. The company anticipates closing two additional sale and leaseback transactions in Texas and Utah.

• ·ADT Wyoming PSA originally dated December 16, 2025, with exhibits filed in prior 8-K on December 17, 2025.
• ·Lease term: 20 years from closing, with four optional 5-year extensions.
• ·Two additional sale and leaseback transactions in Texas and Utah anticipated to close per agreements filed December 17, 2025.

03-03-2026

Bath & Body Works, Inc. issued a notice of redemption on March 3, 2026, for any and all outstanding 6.694% Senior Notes due 2027, with the redemption date set for April 10, 2026. The redemption price will be the greater of 100% of the principal amount or the present value of remaining scheduled payments discounted at the applicable treasury rate plus 50 basis points, plus accrued interest to the redemption date. No specific principal amount outstanding was disclosed in the filing.

• ·Common Stock: $0.50 par value, traded as BBWI on The New York Stock Exchange
• ·Company address: Three Limited Parkway, Columbus, OH 43230
• ·IRS Employer Identification No.: 31-1029810

03-03-2026

First Citizens BancShares, Inc. issued and sold $500M aggregate principal amount of its 4.869% Fixed-to-Floating Rate Senior Notes due 2032 on March 3, 2026, in a public offering. The notes were issued pursuant to a senior base indenture dated March 12, 2025, as supplemented, and an underwriting agreement dated February 25, 2026, with J.P. Morgan Securities LLC, BofA Securities, Inc., and Wells Fargo Securities, LLC as representatives. No period-over-period financial comparisons are provided in the filing.

• ·Registration Statement on Form S-3 filed August 14, 2024 (File No. 333-281553)
• ·Prospectus Supplement dated February 25, 2026, filed February 26, 2026
• ·Senior Base Indenture dated March 12, 2025
• ·Second Supplemental Indenture dated March 3, 2026

03-03-2026

SWK Holdings Corp is proposing a three-step merger where SWK merges into Acquisition Sub (a subsidiary of Intermediary Sub), followed by mergers into Intermediary Sub and then RWAY, with SWK stockholders eligible to receive RWAY common stock per the Exchange Ratio or cash equal to SWK Per Share NAV, plus a pro rata share of a $9M guaranteed cash payment from the Adviser. Total transaction costs are estimated at $6.7M for RWAY and $3.2M for SWK. Pro forma annual expenses for the combined RWAY increase to 16.98% of net assets (from RWAY's actual 16.07%), driven by higher management (3.42% vs 3.11%) and incentive fees (2.83% vs 2.59%), though other expenses slightly decline (1.59% vs 1.68%).

• ·Data based on information as of September 30, 2025.
• ·Exchange Ratio determined within two days prior to Effective Time, subject to anti-dilution adjustments.
• ·RWAY intends quarterly dividends post-merger, consistent with current practice.
• ·SWK Investor Relations contact: (778) 323-0959.

03-03-2026

On February 25, 2026, Babcock & Wilcox Enterprises, Inc. entered into the Tenth Amendment to its Credit Agreement originally dated January 18, 2024, which increases borrowing availability based on inventory and receivables, extends the maturity date to January 18, 2028, suspends the $3M PBGC Reserve (with re-imposition possible on January 1, 2027 if a $3M installment is not paid by September 15, 2026), modifies deposit account covenants, and releases BRC Group Holdings, Inc. as a guarantor. These changes improve liquidity and flexibility without any reported declines in terms. No prior period financial metrics are provided for comparison.

• ·Credit Agreement originally dated January 18, 2024
• ·Registrant address: 1200 EAST MARKET STREET, SUITE 650, AKRON, OHIO 44305
• ·Telephone: (330) 753-4511
• ·IRS Employer Identification No.: 47-2783641
• ·Commission File Number: 001-36876

03-03-2026

U.S. Physical Therapy, Inc. reported strong FY 2025 results with adjusted EBITDA up 16.1% YoY to $95M from $81.8M, net revenue up 16.3% (PT +16%, injury prevention +18%), and operating income +18.4%, despite 2.9% Medicare rate reductions. Q4 2025 adjusted EBITDA rose $3M YoY to $24.8M, PT revenues increased $20M to $173.8M, and visits per clinic per day hit a record 32.7 amid 11.2% total visit growth. Looking ahead, new hospital partnerships are expected to deliver at least $14M EBITDA lift in 2027 (USPH share >$7M post-minority interest) across 70 clinics.

• ·Seven consecutive quarters of record visits per clinic per day through Q4 2025.
• ·PT operating costs down $0.50 per visit in Q4 2025 YoY and up only 1.1% for FY 2025.
• ·Recent acquisitions: Pacific Northwest PT team, home care addition, injury prevention team strengthening NYC presence.
• ·Two new long-term hospital arrangements phasing in mid-2026 for 70 clinics.

03-03-2026

On February 26, 2026, the Compensation Committee of Anteris Technologies Global Corp. approved a one-time discretionary grant of restricted stock units (RSUs) valued at $500,000 to Chief Financial Officer Matthew McDonnell, effective March 4, 2026, under the company's Equity Incentive Plan. The RSUs vest one-third annually over three years, subject to continued employment, with accelerated vesting upon death, disability, or certain change in control events. This special award recognizes Mr. McDonnell's exemplary service and does not affect his target 2026 annual equity awards.

• ·RSUs to be determined by dividing $500,000 by the March 4, 2026 closing price of AVR common stock.
• ·Upon vesting, RSUs settle in CHESS depositary interests.
• ·Filing signed by Wayne Paterson on March 3, 2026.

03-03-2026

RYAM reported Q4 2025 net sales of $417M, down 1% YoY from $422M, and a loss from continuing operations of $21M, worsening $5M from $16M in Q4 2024, with Adjusted EBITDA of $46M also down $5M YoY. While Cellulose Specialties sales rose 2% to $249M and Biomaterials increased 25% to $10M, Paperboard sales fell 27% to $44M and High-Yield Pulp declined 13% to $28M. Full-year revenue reached $1.5B with Adjusted EBITDA of $133M, but cash from operations was $24M and Adjusted Free Cash Flow was negative $88M.

• ·Q4 2025 global liquidity includes $75M cash, $72M ABL borrowing capacity, $10M France factoring availability
• ·Conference call scheduled for March 4, 2026 at 9:00 a.m. ET
• ·Non-operating charges in Q4 2025: $3M AGE project, $2M pension settlement loss, $1M SWEN put option remeasurement

03-03-2026

Diamond Hill Investment Group, Inc. held a special shareholder meeting on March 3, 2026, where shareholders overwhelmingly approved the Merger Agreement with First Eagle Investment Management, LLC's subsidiary, Soar Christopher Holdings, Inc., with 1,911,619 votes for, 3,201 against, and 1,327 abstentions out of 1,916,147 shares present (70.82% quorum of 2,705,580 outstanding shares). The advisory compensation proposal also passed with 1,744,220 votes for versus 144,799 against and 27,128 abstentions. The merger is expected to close in Q2 2026, subject to customary conditions including client consents.

• ·Record date for special meeting: January 27, 2026
• ·Proxy statement filed with SEC on January 28, 2026
• ·Merger expected to close in second quarter of 2026, pending client consents and other conditions
• ·No broker non-votes for either proposal

03-03-2026

Vertiv Holdings Co completed a $2.1B senior unsecured notes offering across 10-, 20-, 30-, and 40-year tranches, raising $2.08B in net proceeds used with cash on hand to fully repay its existing secured term loan, and closed a new $2.5B senior unsecured revolving credit facility with a 5-year maturity, replacing the prior $800M asset-based facility. S&P and Moody’s each upgraded Vertiv’s debt ratings by one notch on February 12 and 19, 2026, achieving investment grade status (Baa3/BBB-/BBB- from Moody’s/S&P/Fitch). These transactions extend debt maturities, enhance liquidity, and provide financial flexibility, with no negative impacts on existing commitments, guarantees, or liens reported.

• ·Notes offering split across four tranches with 10-year, 20-year, 30-year, and 40-year maturities.
• ·Vertiv headquartered in Westerville, Ohio, does business in more than 130 countries.

03-03-2026

Dave Inc. announced the commencement of a private offering of $150 million aggregate principal amount of Convertible Senior Notes due 2031, subject to market and other conditions, offered only to qualified institutional buyers under Rule 144A. Initial purchasers have an option to purchase up to an additional $22.5 million aggregate principal amount within a 13-day settlement period. In connection with the offering, the company expects to enter into privately negotiated capped call transactions with initial purchasers or affiliates.

• ·Notes offered in reliance on Rule 144A for qualified institutional buyers
• ·Option settlement period: 13 days beginning on issuance date
• ·Press release issued pursuant to Rule 135c under the Securities Act

03-03-2026

BrightView Holdings, Inc. held its 2026 Annual Meeting of Stockholders on March 3, 2026, electing eight directors for common stock (e.g., Dale A. Asplund with 131.1M votes for and Jane Okun Bomba with 132.2M votes for) and two directors (Kurtis Barker and Joshua Goldman) for Series A Convertible Preferred Stock with unanimous 500,000 votes for each. While all directors received majority support, significant votes were withheld for James R. Abrahamson (23.5M withheld) and Paul E. Raether (10.3M withheld). Stockholders ratified Deloitte & Touche LLP as the independent auditor for fiscal 2026 with overwhelming support of 139.0M votes for versus 206K against.

• ·Proxy Statement filed with SEC on January 15, 2026
• ·Directors elected for one-year term expiring at 2027 Annual Meeting
• ·5,348 abstentions on auditor ratification

03-03-2026

FirstCash Holdings, Inc. announced the availability of its most recent investor presentation on its corporate website (investors.firstcash.com), furnished as Exhibit 99.1 to this Form 8-K filed on March 3, 2026. The presentation is incorporated by reference in Item 7.01 but is 'furnished' and not deemed 'filed' for liability purposes. No specific financial metrics or performance data are disclosed in the filing itself.

• ·Securities registered: Common Stock, par value $0.01 per share (FCFS) on The Nasdaq Stock Market.
• ·Principal executive offices: 1600 West 7th Street, Fort Worth, Texas 76102.
• ·Telephone: (817) 335-1100.

03-03-2026

Community West Bancshares announced the retirement of Executive Vice President and Chief Operating Officer Blaine C. Lauhon, effective December 31, 2026, concluding his over 40-year banking career, including nearly a decade with the Bank since joining in 2017 via the Folsom Lake Bank acquisition. CEO James J. Kim highlighted Lauhon's leadership in operations, technology, and transformative initiatives, expressing gratitude for his contributions to the Bank's long-term success. No successor was named in the announcement.

• ·Lauhon named Chief Operating Officer in December 2024, Chief Administrative Officer in April 2024, Chief Banking Officer in 2021, Executive Vice President and Market Executive in 2019, and Senior Vice President and Senior Credit Officer in 2017.
• ·Bank headquartered in Fresno, California, established in 1979, first Banking Center opened January 10, 1980.
• ·Full board: Daniel J. Doyle (Chairman), Robert H. Bartlein (Vice Chairman), James J. Kim, Martin E. Plourd, Andriana D. Majarian, Suzanne M. Chadwick, Daniel N. Cunningham, Tom L. Dobyns, F.T. “Tommy” Elliott IV, Robert J. Flautt, James W. Lokey, Steven D. McDonald, Dorothea D. Silva, William S. Smittcamp, Kirk B. Stovesand; Louis C. McMurray (Director Emeritus).

03-03-2026

NeOnc Technologies Holdings, Inc. (NTHI) entered into Securities Purchase Agreements to issue and sell up to 2,222,222 shares of common stock at $7.20 per share and warrants to purchase the same number at $9.00 exercise price. Closings raised $10M from 1,388,888 shares/warrants to one institutional investor, $621,804 from 86,361 shares/warrants to three investors, and $1.45M from 201,390 shares/warrants to four investors, with net proceeds for working capital. The company will file a resale registration statement within 10 days after its Form 10-K for the year ended December 31, 2025.

• ·First Securities Purchase Agreement dated January 29, 2026, terminated January 31, 2026.
• ·Second Securities Purchase Agreement dated February 24, 2026, terminated February 28, 2026.
• ·Securities issued pursuant to Section 4(a)(2) exemption under Securities Act.
• ·Exhibits include Form of Warrant (4.1) and Form of Securities Purchase Agreement (10.1).

03-03-2026

Ventyx Biosciences, Inc. held a special shareholder meeting on March 3, 2026, where Proposal 1 to approve the Merger Agreement with Eli Lilly and Company received overwhelming support with 44,176,785 votes FOR (96.4% of votes cast) versus 1,572,592 AGAINST out of 45,810,746 shares present or by proxy. Proposal 2 on advisory executive compensation approval also passed with 43,789,693 FOR (95.6%). As of the January 21, 2026 record date, 71,760,778 common shares were outstanding.

• ·Merger Agreement dated January 7, 2026; special meeting at 10:00 a.m. Pacific time on March 3, 2026.
• ·Proxy statement dated February 2, 2026, amended February 23, 2026.
• ·Proposal 3 (adjournment) rendered moot and not presented.

03-03-2026

On February 27, 2026, the Compensation Committee of CVRx, Inc.'s Board of Directors approved incremental performance stock units (PSUs) to all executive officers, valued at three-fourths of their fiscal 2026 annual long-term incentives, tied to a competitively sensitive cumulative revenue goal for the fiscal 2026-2027 performance period. The PSUs can vest between 50% at threshold performance and 200% at maximum, with 50% settling upon certification post-period and the remaining 50% on December 31, 2028, subject to continued employment. The awards aim to retain executives amid criticality of near-term revenue objectives.

• ·PSUs convert to time-based RSUs at greater of target or actual performance upon change in control.
• ·Vesting includes provisions for accelerated vesting on death, disability, termination without cause, or double-trigger change in control.
• ·Form of PSU Agreement filed as Exhibit 10.1.

03-03-2026

CVR Partners, LP disclosed the death of independent director Brian A. Goebel on February 20, 2026, reducing the Board to five members (two independent) and the Audit Committee to two independent members, causing non-compliance with NYSE Listed Company Manual Section 303A.07(a), which requires at least three independent audit committee members. The Partnership notified NYSE on February 25, 2026, and received formal notice of non-compliance on March 3, 2026. The company has begun searching for a replacement independent director to regain compliance promptly.

• ·Mr. Goebel joined the Board in October 2025.
• ·Compliance to be regained upon appointing a new independent Audit Committee member meeting NYSE and SEC independence requirements.
• ·Principal executive offices: 2277 Plaza Drive, Suite 500, Sugar Land, Texas 77479; Phone: (281) 207-3200.